TREAT CASP — A Blood Pressure Study at UCL

The TREAT CASP Study is a National Institute for Health Research (NIHR) funded study run by University College London. The study aim is to find the best way to measure blood pressure in young men (aged 18-54 years) with mildly raised blood pressure. Information from this study should help doctors to accurately identify which young people are most likely to benefit from blood pressure lowering treatment.

Recruitment into the TREAT CASP study was completed in January 2017.  The study is no longer seeking new participants

The TREAT CASP study uses a novel non-invasive device to measure blood pressure. This looks like a wrist watch and can tell us what central blood pressure is, rather than measuring blood pressure in the arm in the way that existing monitors work. Central blood pressure (the pressure in the main artery leaving the heart) is probably more important than the pressure in the arm for long-term health. The two pressures can be surprisingly different, particularly in young people. Therefore, this new approach could lead to a major advance in blood pressure management.


Why is it important to measure blood pressure accurately?

Raised blood pressure (which is known as hypertension) increases the risk of heart attacks and strokes. About a quarter of adults in the UK have hypertension. This can be treated effectively with medication but not without a small risk of side-effects. Therefore, it is important to treat only those for whom the benefits will outweigh the risks. Nonetheless, early treatment is likely to achieve the greatest long-term benefit, so it is important to identify the people who need this. In this way, we should be able to reduce the number of people who suffer from heart attacks or strokes. The TREAT CASP study represents an opportunity to test whether we can use this new technology to identify people who may benefit from early intervention to lower blood pressure.

Page last modified on 28 feb 17 15:31